Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)

This publication has 20 references indexed in Scilit:

• Intermittent inotropic therapy in an outpatient setting: A cost-effective therapeutic modality in patients with refractory heart failure
  American Heart Journal, 1996
• Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: Results of the studies of left ventricular dysfunctions (SOLVD) registry
  Journal of the American College of Cardiology, 1993
• I. Introduction
  Journal of the American College of Cardiology, 1988
• Short‐ and long‐term dobutamine treatment in chronic ischemic heart failure
  Clinical Cardiology, 1987
• Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure
  American Heart Journal, 1986
• Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
  New England Journal of Medicine, 1984
• Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.
  Circulation, 1984
• Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.
  Heart, 1983
• The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy
  American Heart Journal, 1983
• Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure
  The American Journal of Cardiology, 1983